Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Activated Protein C for Acute Lung Injury
NCT00112164Phase 2Terminated
- Sponsor
- University of California, San Francisco
- Start
- Jan 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of drotrecogin alfa in acute lung injury (ALI), sponsored by University of California, San Francisco. Started Jan 2005; status: terminated.
02
Drugs
drotrecogin alfa
03
Conditions
acute lung injury (ALI)
Beyond the preview
Go deeper on NCT00112164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00112164.